Michael Ulz – Baird

Baird

A Baird analyst with 9 tracked ratings covering 5 distinct tickers has a 25% success rate on the captured sample, focusing on ratings from two sources.

Aggregated from multiple market-data sources

Total ratings

Tickers covered

Sources

Aggregated

Latest rating

2 months ago

2026-03-25 00:00:00+00

Track record

Aggregated

25% success rate

Bullish: 0
Hold: 0
Bearish: 0

Aggregated

Not available

Bullish: 6
Hold: 0
Bearish: 0

Recent ratings

Ticker	Date	Rating	Price target	Source
KPTI	2026-03-25	buy	$15.00	Aggregated
KPTI	2025-10-09	buy	$21.00	Aggregated
KPTIKARYOPHARM THERAPEUTICS INC	2025-10-09	unknown	$21.00	Aggregated
KPTI	2025-08-12	buy	$25.00	Aggregated
KPTI	2025-05-13	buy	$42.00	Aggregated
KPTI	2025-03-03	buy	$54.00	Aggregated
IOVA	2025-02-28	buy	$20.00	Aggregated
IOVAIOVANCE BIOTHERAPEUTICS INC	2025-02-28	unknown	$20.00	Aggregated
ORICORIC PHARMACEUTICALS INC	2023-08-16	unknown	$27.00	Aggregated

Tickers covered(5)

Ticker	Ratings	Last rating	Sources
KPTI	5	2026-03-25	Aggregated
KPTIKARYOPHARM THERAPEUTICS INC	1	2025-10-09	Aggregated
IOVA	1	2025-02-28	Aggregated
IOVAIOVANCE BIOTHERAPEUTICS INC	1	2025-02-28	Aggregated
ORICORIC PHARMACEUTICALS INC	1	2023-08-16	Aggregated

Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.